331 related articles for article (PubMed ID: 24290367)
1. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.
Diniz BS; Reynolds CF; Begley A; Dew MA; Anderson SJ; Lotrich F; Erickson KI; Lopez O; Aizenstein H; Sibille EL; Butters MA
J Psychiatr Res; 2014 Feb; 49():96-101. PubMed ID: 24290367
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.
Reynolds CF; Butters MA; Lopez O; Pollock BG; Dew MA; Mulsant BH; Lenze EJ; Holm M; Rogers JC; Mazumdar S; Houck PR; Begley A; Anderson S; Karp JF; Miller MD; Whyte EM; Stack J; Gildengers A; Szanto K; Bensasi S; Kaufer DI; Kamboh MI; DeKosky ST
Arch Gen Psychiatry; 2011 Jan; 68(1):51-60. PubMed ID: 21199965
[TBL] [Abstract][Full Text] [Related]
3. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.
Diniz BS; Teixeira AL; Machado-Vieira R; Talib LL; Radanovic M; Gattaz WF; Forlenza OV
J Gerontol B Psychol Sci Soc Sci; 2014 Nov; 69(6):845-51. PubMed ID: 25149921
[TBL] [Abstract][Full Text] [Related]
4. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
5. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Mold-Fermented Cheese on Brain-Derived Neurotrophic Factor in Community-Dwelling Older Japanese Women With Mild Cognitive Impairment: A Randomized, Controlled, Crossover Trial.
Suzuki T; Kojima N; Osuka Y; Tokui Y; Takasugi S; Kawashima A; Yamaji T; Hosoi E; Won CW; Kim H
J Am Med Dir Assoc; 2019 Dec; 20(12):1509-1514.e2. PubMed ID: 31562049
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and BDNF serum levels.
Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
[TBL] [Abstract][Full Text] [Related]
8. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG
J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294
[TBL] [Abstract][Full Text] [Related]
9. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.
Leyhe T; Stransky E; Eschweiler GW; Buchkremer G; Laske C
Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258(2):124-8. PubMed ID: 17990049
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.
Ng TKS; Coughlan C; Heyn PC; Tagawa A; Carollo JJ; Kua EH; Mahendran R
Aging (Albany NY); 2021 Oct; 13(19):22666-22689. PubMed ID: 34607976
[TBL] [Abstract][Full Text] [Related]
11. Late-life depression and increased risk of dementia: a longitudinal cohort study.
Ly M; Karim HT; Becker JT; Lopez OL; Anderson SJ; Aizenstein HJ; Reynolds CF; Zmuda MD; Butters MA
Transl Psychiatry; 2021 Mar; 11(1):147. PubMed ID: 33654078
[TBL] [Abstract][Full Text] [Related]
12. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.
Pelton GH; Andrews H; Roose SP; Marcus SM; D'Antonio K; Husn H; Petrella JR; Zannas AS; Doraiswamy PM; Devanand DP
Contemp Clin Trials; 2014 Mar; 37(2):200-8. PubMed ID: 24315979
[TBL] [Abstract][Full Text] [Related]
13. Reduced Serum Levels of Brain-Derived Neurotrophic Factor Are Related to Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
Sun ZC; Yu J; Liu YL; Hong ZZ; Ling L; Li GQ; Zhuo YF; Wang WR; Zhang Y
Ann Nutr Metab; 2018; 73(4):271-281. PubMed ID: 30308512
[TBL] [Abstract][Full Text] [Related]
14. Association of late-life depression with cognitive impairment: evidence from a cross-sectional study among older adults in India.
Muhammad T; Meher T
BMC Geriatr; 2021 Jun; 21(1):364. PubMed ID: 34130632
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
Pelton GH; Harper OL; Tabert MH; Sackeim HA; Scarmeas N; Roose SP; Devanand DP
Int J Geriatr Psychiatry; 2008 Jul; 23(7):670-6. PubMed ID: 18088076
[TBL] [Abstract][Full Text] [Related]
16. MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression.
Lebedeva AK; Westman E; Borza T; Beyer MK; Engedal K; Aarsland D; Selbaek G; Haberg AK
Front Aging Neurosci; 2017; 9():13. PubMed ID: 28210220
[No Abstract] [Full Text] [Related]
17. Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.
Diniz BS; Sibille E; Ding Y; Tseng G; Aizenstein HJ; Lotrich F; Becker JT; Lopez OL; Lotze MT; Klunk WE; Reynolds CF; Butters MA
Mol Psychiatry; 2015 May; 20(5):594-601. PubMed ID: 25092249
[TBL] [Abstract][Full Text] [Related]
18. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
19. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
[TBL] [Abstract][Full Text] [Related]
20. Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial.
Montero-Odasso M; Wells JL; Borrie MJ; Speechley M
BMC Neurol; 2009 Aug; 9():42. PubMed ID: 19674471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
